|
|
Volumn 17, Issue 11, 2014, Pages 792-797
|
|
Costs associated with adverse events in patients with metastatic renal cell carcinoma
a
|
|
Author keywords
Adverse events; Cost; Renal cell carcinoma
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
PAZOPANIB;
SORAFENIB;
SUNITINIB;
ABDOMINAL PAIN;
ADULT;
ADVERSE DRUG REACTION;
ARTICLE;
ASTHENIA;
BACKACHE;
CANCER CHEMOTHERAPY;
CANCER FATIGUE;
CANCER PAIN;
CANCER PATIENT;
CASE FINDING;
CHEMOTHERAPY INDUCED NAUSEA AND VOMITING;
COHORT ANALYSIS;
CONTROLLED STUDY;
DIARRHEA;
DISEASE ASSOCIATION;
DYSPNEA;
FEBRILE NEUTROPENIA;
FEMALE;
HAND FOOT SYNDROME;
HEALTH CARE COST;
HUMAN;
HYPERTENSION;
ICD-9-CM;
KIDNEY METASTASIS;
LIMB PAIN;
LYMPHOCYTOPENIA;
MAJOR CLINICAL STUDY;
MALE;
PROTEINURIA;
RETROSPECTIVE STUDY;
THROMBOCYTOPENIA;
ADOLESCENT;
AGE;
AGED;
CARCINOMA, RENAL CELL;
INSURANCE;
KIDNEY NEOPLASMS;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
SEX DIFFERENCE;
STATISTICS AND NUMERICAL DATA;
YOUNG ADULT;
ADOLESCENT;
ADULT;
AGE FACTORS;
AGED;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
FEMALE;
HEALTH EXPENDITURES;
HUMANS;
INSURANCE CLAIM REVIEW;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
RETROSPECTIVE STUDIES;
SEX FACTORS;
YOUNG ADULT;
|
|
EID: 84911494391
PISSN: 13696998
EISSN: 1941837X
Source Type: Journal
DOI: 10.3111/13696998.2014.945645 Document Type: Article |
|
Times cited : (9)
|
|
References (9)
|
